[1]
Guarino MP,Cocca S,Altomare A,Emerenziani S,Cicala M, Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed. World journal of gastroenterology. 2013 Aug 21;
[PubMed PMID: 23964136]
[2]
Makino I,Tanaka H, From a choleretic to an immunomodulator: historical review of ursodeoxycholic acid as a medicament. Journal of gastroenterology and hepatology. 1998 Jun;
[PubMed PMID: 9715413]
[3]
Roma MG,Toledo FD,Boaglio AC,Basiglio CL,Crocenzi FA,Sánchez Pozzi EJ, Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications. Clinical science (London, England : 1979). 2011 Dec;
[PubMed PMID: 21854363]
[4]
Lazaridis KN,Gores GJ,Lindor KD, Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. Journal of hepatology. 2001 Jul;
[PubMed PMID: 11495032]
[5]
Copaci I,Micu L,Iliescu L,Voiculescu M, New therapeutical indications of ursodeoxycholic acid. Romanian journal of gastroenterology. 2005 Sep;
[PubMed PMID: 16200237]
[6]
Chascsa D,Carey EJ,Lindor KD, Old and new treatments for primary biliary cholangitis. Liver international : official journal of the International Association for the Study of the Liver. 2017 Apr;
[PubMed PMID: 28371104]
[7]
Patel A,Seetharam A, Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics. Journal of clinical and experimental hepatology. 2016 Dec;
[PubMed PMID: 28003721]
[8]
Tabibian JH,Ali AH,Lindor KD, Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment. Gastroenterology
[PubMed PMID: 29991937]
[9]
Kong X,Kong Y,Zhang F,Wang T,Yan J, Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study). Medicine. 2016 Oct;
[PubMed PMID: 27749550]
Level 1 (high-level) evidence
[10]
Ward JBJ,Lajczak NK,Kelly OB,O'Dwyer AM,Giddam AK,Ní Gabhann J,Franco P,Tambuwala MM,Jefferies CA,Keely S,Roda A,Keely SJ, Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon. American journal of physiology. Gastrointestinal and liver physiology. 2017 Jun 1;
[PubMed PMID: 28360029]
[11]
Ljubuncic P,Fuhrman B,Oiknine J,Aviram M,Bomzon A, Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages. Gut. 1996 Sep;
[PubMed PMID: 8949657]
[12]
Combes B,Carithers RL Jr,Maddrey WC,Munoz S,Garcia-Tsao G,Bonner GF,Boyer JL,Luketic VA,Shiffman ML,Peters MG,White H,Zetterman RK,Risser R,Rossi SS,Hofmann AF, Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology (Baltimore, Md.). 1999 Jun;
[PubMed PMID: 10347103]
[13]
Jazrawi RP,de Caestecker JS,Goggin PM,Britten AJ,Joseph AE,Maxwell JD,Northfield TC, Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology. 1994 Jan;
[PubMed PMID: 8276175]
[15]
Medina JF,Martínez-Ansó,Vazquez JJ,Prieto J, Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology (Baltimore, Md.). 1997 Jan;
[PubMed PMID: 8985258]
[16]
Hillaire S,Boucher E,Calmus Y,Gane P,Ballet F,Franco D,Moukthar M,Poupon R, Effects of bile acids and cholestasis on major histocompatibility complex class I in human and rat hepatocytes. Gastroenterology. 1994 Sep;
[PubMed PMID: 8076765]
[17]
Saksena S,Tandon RK, Ursodeoxycholic acid in the treatment of liver diseases. Postgraduate medical journal. 1997 Feb;
[PubMed PMID: 9122101]
[18]
Hempfling W,Dilger K,Beuers U, Systematic review: ursodeoxycholic acid--adverse effects and drug interactions. Alimentary pharmacology
[PubMed PMID: 14616161]
Level 1 (high-level) evidence
[19]
Bessone F,Roma MG, Is ursodeoxycholic acid detrimental in obstructive cholestasis? A propos of a case of malignant biliary obstruction. Annals of hepatology. 2016 May-Jun;
[PubMed PMID: 27049500]
Level 3 (low-level) evidence
[20]
Verma A,Jazrawi RP,Ahmed HA,Davis T,Bland JM,Benson M,Orchard RT,Theodossi A,Maxwell JD,Northfield TC, Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis. European journal of gastroenterology
[PubMed PMID: 10524634]
[22]
Bahar R,Wong KA,Liu CH,Bowlus CL, Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis. Gastroenterology
[PubMed PMID: 29928160]